HEADER HYDROLASE 05-DEC-01 1ISG TITLE CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 WITH ATPGAMMAS COMPND MOL_ID: 1; COMPND 2 MOLECULE: BONE MARROW STROMAL CELL ANTIGEN 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: EXTRACELLULAR REGION; COMPND 5 SYNONYM: BST-1/CD157, ADP-RIBOSYL CYCLASE 2; COMPND 6 EC: 3.2.2.5; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: AUTOGRAPHA CALIFORNICA NUCLEAR SOURCE 11 POLYHEDROSIS VIRUS KEYWDS ADP RIBOSYLCYCLASE, NAD GLYCOHYDROLASE, CNS, ATPGAMMAS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.YAMAMOTO-KATAYAMA,M.ARIYOSHI,K.ISHIHARA,T.HIRANO,H.JINGAMI, AUTHOR 2 K.MORIKAWA REVDAT 8 27-DEC-23 1ISG 1 REMARK REVDAT 7 10-NOV-21 1ISG 1 SEQADV HETSYN REVDAT 6 29-JUL-20 1ISG 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 15-FEB-12 1ISG 1 HET HETATM REVDAT 4 13-JUL-11 1ISG 1 VERSN REVDAT 3 24-FEB-09 1ISG 1 VERSN REVDAT 2 07-JAN-03 1ISG 1 REMARK REVDAT 1 13-MAR-02 1ISG 0 JRNL AUTH S.YAMAMOTO-KATAYAMA,M.ARIYOSHI,K.ISHIHARA,T.HIRANO, JRNL AUTH 2 H.JINGAMI,K.MORIKAWA JRNL TITL CRYSTALLOGRAPHIC STUDIES ON HUMAN BST-1/CD157 WITH JRNL TITL 2 ADP-RIBOSYL CYCLASE AND NAD GLYCOHYDROLASE ACTIVITIES. JRNL REF J.MOL.BIOL. V. 316 711 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 11866528 JRNL DOI 10.1006/JMBI.2001.5386 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.YAMAMOTO-KATAYAMA,A.SATO,M.ARIYOSHI,M.SUYAMA,K.ISHIHARA, REMARK 1 AUTH 2 T.HIRANO,H.NAKAMURA,K.MORIKAWA,H.JINGAMI REMARK 1 TITL SITE-DIRECTED REMOVAL OF N-GLYCOSYLATION SITES IN REMARK 1 TITL 2 BST-1/CD157: EFFECTS ON MOLECULAR AND FUNCTIONAL REMARK 1 TITL 3 HETEROGENEITY REMARK 1 REF BIOCHEM.J. V. 357 385 2001 REMARK 1 REFN ISSN 0264-6021 REMARK 1 PMID 11439087 REMARK 1 DOI 10.1042/0264-6021:3570385 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 26500 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1958 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3693 REMARK 3 BIN R VALUE (WORKING SET) : 0.2920 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 287 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4010 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 118 REMARK 3 SOLVENT ATOMS : 89 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 23.42000 REMARK 3 B22 (A**2) : -8.99000 REMARK 3 B33 (A**2) : -14.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.39 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.45 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.850 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.970 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.220 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 34.57 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ATS.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN_REP.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ATS.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ISG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-DEC-01. REMARK 100 THE DEPOSITION ID IS D_1000005233. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL24XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.836 REMARK 200 MONOCHROMATOR : SILICON CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26538 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 31.20 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 33.60 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, CITRATE, ATPGAMMAS, REMARK 280 PH 4.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.28650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.26350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 56.42550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.26350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.28650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 56.42550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 1 REMARK 465 SER A 252 REMARK 465 ALA A 253 REMARK 465 ALA A 254 REMARK 465 ALA A 255 REMARK 465 ALA A 256 REMARK 465 THR A 257 REMARK 465 GLN A 258 REMARK 465 ARG A 259 REMARK 465 LYS A 260 REMARK 465 ALA A 261 REMARK 465 PRO A 262 REMARK 465 SER A 263 REMARK 465 LEU A 264 REMARK 465 TYR A 265 REMARK 465 ARG B 1 REMARK 465 SER B 252 REMARK 465 ALA B 253 REMARK 465 ALA B 254 REMARK 465 ALA B 255 REMARK 465 ALA B 256 REMARK 465 THR B 257 REMARK 465 GLN B 258 REMARK 465 ARG B 259 REMARK 465 LYS B 260 REMARK 465 ALA B 261 REMARK 465 PRO B 262 REMARK 465 SER B 263 REMARK 465 LEU B 264 REMARK 465 TYR B 265 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 3 51.53 -95.25 REMARK 500 PRO A 50 -4.49 -56.38 REMARK 500 SER A 80 30.31 -152.09 REMARK 500 PHE A 108 -3.12 74.29 REMARK 500 CYS A 112 142.49 171.65 REMARK 500 ALA A 116 60.03 -117.98 REMARK 500 HIS A 242 47.62 -145.01 REMARK 500 PRO B 50 -9.94 -47.81 REMARK 500 SER B 80 35.70 -158.14 REMARK 500 ASN B 90 70.48 51.00 REMARK 500 THR B 91 -5.92 60.84 REMARK 500 PHE B 108 -19.24 70.97 REMARK 500 CYS B 112 150.08 173.04 REMARK 500 ASP B 117 155.66 174.41 REMARK 500 CYS B 131 148.93 -178.93 REMARK 500 ASN B 202 66.39 -100.95 REMARK 500 HIS B 242 46.93 -152.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ISF RELATED DB: PDB REMARK 900 1ISF CONTAINS THE SAME PROTEIN (LIGAND FREE FORM). REMARK 900 RELATED ID: 1ISH RELATED DB: PDB REMARK 900 1ISH CONTAINS THE SAME PROTEIN COMPLEXED WITH ETHENONADP. REMARK 900 RELATED ID: 1ISI RELATED DB: PDB REMARK 900 1ISI CONTAINS THE SAME PROTEIN COMPLEXED WITH ETHENONAD. REMARK 900 RELATED ID: 1ISJ RELATED DB: PDB REMARK 900 1ISJ CONTAINS THE SAME PROTEIN COMPLEXED WITH NMN. REMARK 900 RELATED ID: 1ISM RELATED DB: PDB REMARK 900 1ISM CONTAINS THE SAME PROTEIN COMPLEXED WITH NICOTINAMIDE. DBREF 1ISG A 1 265 UNP Q10588 BST1_HUMAN 33 297 DBREF 1ISG B 1 265 UNP Q10588 BST1_HUMAN 33 297 SEQADV 1ISG ASP A 34 UNP Q10588 ASN 66 ENGINEERED MUTATION SEQADV 1ISG THR A 63 UNP Q10588 ASN 95 ENGINEERED MUTATION SEQADV 1ISG ALA A 116 UNP Q10588 ASN 148 ENGINEERED MUTATION SEQADV 1ISG ASP B 34 UNP Q10588 ASN 66 ENGINEERED MUTATION SEQADV 1ISG THR B 63 UNP Q10588 ASN 95 ENGINEERED MUTATION SEQADV 1ISG ALA B 116 UNP Q10588 ASN 148 ENGINEERED MUTATION SEQRES 1 A 265 ARG TRP ARG ALA GLU GLY THR SER ALA HIS LEU ARG ASP SEQRES 2 A 265 ILE PHE LEU GLY ARG CYS ALA GLU TYR ARG ALA LEU LEU SEQRES 3 A 265 SER PRO GLU GLN ARG ASN LYS ASP CYS THR ALA ILE TRP SEQRES 4 A 265 GLU ALA PHE LYS VAL ALA LEU ASP LYS ASP PRO CYS SER SEQRES 5 A 265 VAL LEU PRO SER ASP TYR ASP LEU PHE ILE THR LEU SER SEQRES 6 A 265 ARG HIS SER ILE PRO ARG ASP LYS SER LEU PHE TRP GLU SEQRES 7 A 265 ASN SER HIS LEU LEU VAL ASN SER PHE ALA ASP ASN THR SEQRES 8 A 265 ARG ARG PHE MET PRO LEU SER ASP VAL LEU TYR GLY ARG SEQRES 9 A 265 VAL ALA ASP PHE LEU SER TRP CYS ARG GLN LYS ALA ASP SEQRES 10 A 265 SER GLY LEU ASP TYR GLN SER CYS PRO THR SER GLU ASP SEQRES 11 A 265 CYS GLU ASN ASN PRO VAL ASP SER PHE TRP LYS ARG ALA SEQRES 12 A 265 SER ILE GLN TYR SER LYS ASP SER SER GLY VAL ILE HIS SEQRES 13 A 265 VAL MET LEU ASN GLY SER GLU PRO THR GLY ALA TYR PRO SEQRES 14 A 265 ILE LYS GLY PHE PHE ALA ASP TYR GLU ILE PRO ASN LEU SEQRES 15 A 265 GLN LYS GLU LYS ILE THR ARG ILE GLU ILE TRP VAL MET SEQRES 16 A 265 HIS GLU ILE GLY GLY PRO ASN VAL GLU SER CYS GLY GLU SEQRES 17 A 265 GLY SER MET LYS VAL LEU GLU LYS ARG LEU LYS ASP MET SEQRES 18 A 265 GLY PHE GLN TYR SER CYS ILE ASN ASP TYR ARG PRO VAL SEQRES 19 A 265 LYS LEU LEU GLN CYS VAL ASP HIS SER THR HIS PRO ASP SEQRES 20 A 265 CYS ALA LEU LYS SER ALA ALA ALA ALA THR GLN ARG LYS SEQRES 21 A 265 ALA PRO SER LEU TYR SEQRES 1 B 265 ARG TRP ARG ALA GLU GLY THR SER ALA HIS LEU ARG ASP SEQRES 2 B 265 ILE PHE LEU GLY ARG CYS ALA GLU TYR ARG ALA LEU LEU SEQRES 3 B 265 SER PRO GLU GLN ARG ASN LYS ASP CYS THR ALA ILE TRP SEQRES 4 B 265 GLU ALA PHE LYS VAL ALA LEU ASP LYS ASP PRO CYS SER SEQRES 5 B 265 VAL LEU PRO SER ASP TYR ASP LEU PHE ILE THR LEU SER SEQRES 6 B 265 ARG HIS SER ILE PRO ARG ASP LYS SER LEU PHE TRP GLU SEQRES 7 B 265 ASN SER HIS LEU LEU VAL ASN SER PHE ALA ASP ASN THR SEQRES 8 B 265 ARG ARG PHE MET PRO LEU SER ASP VAL LEU TYR GLY ARG SEQRES 9 B 265 VAL ALA ASP PHE LEU SER TRP CYS ARG GLN LYS ALA ASP SEQRES 10 B 265 SER GLY LEU ASP TYR GLN SER CYS PRO THR SER GLU ASP SEQRES 11 B 265 CYS GLU ASN ASN PRO VAL ASP SER PHE TRP LYS ARG ALA SEQRES 12 B 265 SER ILE GLN TYR SER LYS ASP SER SER GLY VAL ILE HIS SEQRES 13 B 265 VAL MET LEU ASN GLY SER GLU PRO THR GLY ALA TYR PRO SEQRES 14 B 265 ILE LYS GLY PHE PHE ALA ASP TYR GLU ILE PRO ASN LEU SEQRES 15 B 265 GLN LYS GLU LYS ILE THR ARG ILE GLU ILE TRP VAL MET SEQRES 16 B 265 HIS GLU ILE GLY GLY PRO ASN VAL GLU SER CYS GLY GLU SEQRES 17 B 265 GLY SER MET LYS VAL LEU GLU LYS ARG LEU LYS ASP MET SEQRES 18 B 265 GLY PHE GLN TYR SER CYS ILE ASN ASP TYR ARG PRO VAL SEQRES 19 B 265 LYS LEU LEU GLN CYS VAL ASP HIS SER THR HIS PRO ASP SEQRES 20 B 265 CYS ALA LEU LYS SER ALA ALA ALA ALA THR GLN ARG LYS SEQRES 21 B 265 ALA PRO SER LEU TYR MODRES 1ISG ASN A 160 ASN GLYCOSYLATION SITE MODRES 1ISG ASN B 160 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET AGS A1002 31 HET AGS B1001 31 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN AGS ATP-GAMMA-S; ADENOSINE 5'-(3-THIOTRIPHOSPHATE); HETSYN 2 AGS ADENOSINE 5'-(GAMMA-THIOTRIPHOSPHATE); ADENOSINE-5'- HETSYN 3 AGS DIPHOSPHATE MONOTHIOPHOSPHATE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 5 AGS 2(C10 H16 N5 O12 P3 S) FORMUL 7 HOH *89(H2 O) HELIX 1 1 HIS A 10 LEU A 26 1 17 HELIX 2 2 ASP A 34 LYS A 43 1 10 HELIX 3 3 VAL A 44 LYS A 48 5 5 HELIX 4 4 LEU A 54 ASP A 57 5 4 HELIX 5 5 TYR A 58 ARG A 66 1 9 HELIX 6 6 SER A 80 ASP A 89 1 10 HELIX 7 7 PRO A 96 ASP A 99 5 4 HELIX 8 8 VAL A 100 VAL A 105 1 6 HELIX 9 9 ASN A 134 ASP A 150 1 17 HELIX 10 10 GLY A 172 GLU A 178 1 7 HELIX 11 11 GLN A 183 GLU A 185 5 3 HELIX 12 12 GLY A 209 MET A 221 1 13 HELIX 13 13 TYR A 231 VAL A 240 1 10 HELIX 14 14 HIS A 245 ALA A 249 5 5 HELIX 15 15 HIS B 10 LEU B 25 1 16 HELIX 16 16 LEU B 26 LEU B 26 5 1 HELIX 17 17 SER B 27 ARG B 31 5 5 HELIX 18 18 ASP B 34 ASP B 47 1 14 HELIX 19 19 LEU B 54 ASP B 57 5 4 HELIX 20 20 TYR B 58 ARG B 66 1 9 HELIX 21 21 SER B 80 ASP B 89 1 10 HELIX 22 22 PRO B 96 ASP B 99 5 4 HELIX 23 23 VAL B 100 VAL B 105 1 6 HELIX 24 24 ASN B 134 ASP B 150 1 17 HELIX 25 25 GLY B 172 GLU B 178 1 7 HELIX 26 26 ILE B 179 LEU B 182 5 4 HELIX 27 27 GLN B 183 GLU B 185 5 3 HELIX 28 28 GLY B 209 GLY B 222 1 14 HELIX 29 29 TYR B 231 VAL B 240 1 10 HELIX 30 30 HIS B 245 ALA B 249 5 5 SHEET 1 A 4 LEU A 75 TRP A 77 0 SHEET 2 A 4 GLY A 153 ASN A 160 1 O HIS A 156 N PHE A 76 SHEET 3 A 4 ILE A 187 MET A 195 1 O GLU A 191 N ILE A 155 SHEET 4 A 4 TYR A 225 ASN A 229 1 O SER A 226 N ILE A 192 SHEET 1 B 2 ALA B 4 GLU B 5 0 SHEET 2 B 2 SER B 124 CYS B 125 -1 O CYS B 125 N ALA B 4 SHEET 1 C 4 LEU B 75 TRP B 77 0 SHEET 2 C 4 GLY B 153 ASN B 160 1 O HIS B 156 N PHE B 76 SHEET 3 C 4 ILE B 187 MET B 195 1 O TRP B 193 N VAL B 157 SHEET 4 C 4 TYR B 225 ASN B 229 1 O ILE B 228 N VAL B 194 SSBOND 1 CYS A 19 CYS A 35 1555 1555 2.03 SSBOND 2 CYS A 51 CYS A 131 1555 1555 2.04 SSBOND 3 CYS A 112 CYS A 125 1555 1555 2.03 SSBOND 4 CYS A 206 CYS A 227 1555 1555 2.04 SSBOND 5 CYS A 239 CYS A 248 1555 1555 2.04 SSBOND 6 CYS B 19 CYS B 35 1555 1555 2.05 SSBOND 7 CYS B 51 CYS B 131 1555 1555 2.04 SSBOND 8 CYS B 112 CYS B 125 1555 1555 2.04 SSBOND 9 CYS B 206 CYS B 227 1555 1555 2.04 SSBOND 10 CYS B 239 CYS B 248 1555 1555 2.03 LINK ND2 ASN A 160 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN B 160 C1 NAG D 1 1555 1555 1.46 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.38 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.38 CRYST1 58.573 112.851 130.527 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017073 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008861 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007661 0.00000